Therapeutic idiotype vaccines in B lymphoproliferative diseases.


The recognition of the surface immunoglobulin protein of the tumour B cells as a specific tumour antigen has prompted the development of vaccination strategies aimed at the induction of humoral and cellular antitumour responses. Results obtained in preclinical models of B lymphoproliferative diseases, as well as in initial clinical trials, have shown the… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics